Sp1 transcription factor as a target for anthracyclines: effects on gene transcription

Area of Science:

• Molecular Biology
• Cancer Research
• Pharmacology

Background:

• Anthracyclines are crucial in cancer chemotherapy, but their mechanisms, particularly interference with DNA-protein complexes and gene transcription, require further elucidation.
• Understanding how anthracyclines affect transcription factors like Sp1 is key to developing more specific and effective anti-tumour therapies.
• Daunorubicin and novel bisintercalating anthracyclines like WP631 offer distinct DNA-binding properties that warrant comparative analysis.

Purpose of the Study:

• To compare the efficacy of daunorubicin and the bisintercalating anthracycline WP631 in inhibiting Sp1-DNA interactions and Sp1-activated gene transcription.
• To evaluate the impact of these anthracyclines on gene expression profiles, cell cycle progression, and cell death pathways in human cell lines.
• To provide insights for the development of novel, more specific anti-tumour agents based on anthracycline mechanisms.

Main Methods:

• Comparative in vitro analysis of daunorubicin and WP631's inhibition of Sp1-DNA interactions.
• Assessment of Sp1-activated transcription inhibition in both cell-free systems and human cell lines.
• Gene expression profiling using arrays to analyze transcriptome changes induced by anthracyclines.
• Evaluation of cell cycle arrest and time-dependent cell death responses.

Main Results:

• WP631 demonstrated superior inhibition of transcription initiation at Sp1-binding sites compared to daunorubicin.
• WP631 proved to be a potent inhibitor of Sp1-activated transcription both in vitro and in human cell lines.
• Anthracycline treatment induced significant changes in gene expression, affecting genes with Sp1-binding sites.
• Observed transcriptome alterations correlated with cell cycle arrest and a time-dependent induction of cell death via distinct pathways.

Conclusions:

• WP631 exhibits enhanced potency in inhibiting Sp1-mediated transcription compared to daunorubicin.
• Anthracycline-induced transcriptome modulation plays a critical role in triggering cell cycle arrest and subsequent cell death.
• The specific anthracycline and its concentration dictate the downstream cellular responses, offering a basis for designing targeted anti-cancer drugs.